Anna Poullard, NP

Anna Poullard practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Anna Poullard's NPI, 1457618134, was assigned on April 18, 2012. Anna Poullard holds Texas license AP121150.

Anna Poullard's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Anna Poullard's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Anna Poullard practices. Vendor and product names are available with a free account.

Acute care is Anna Poullard's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Dmand AI has Anna Poullard's licenses on file in 2 states: Texas and Louisiana.

CMS counts 60 Medicare patients who saw Anna Poullard in 2024. The largest group is 65 to 74, with 43 patients. 72% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anna Poullard's median patient age at 67, with 58% women.

In 2024, Anna Poullard wrote 138 Medicare Part D claims for 56 patients. 81% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Anna Poullard for performance year 2024, reported as part of a group. Anna Poullard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anna Poullard as offering telehealth.

CMS Open Payments shows 1 general payment to Anna Poullard from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $119.